中国药物评价
中國藥物評價
중국약물평개
Chinese Journal of Drug Evaluation
2014年
4期
237-242
,共6页
马骏捷%徐丹妮%马爱霞
馬駿捷%徐丹妮%馬愛霞
마준첩%서단니%마애하
依达拉奉%尼莫地平%颅脑损伤%间接Meta分析
依達拉奉%尼莫地平%顱腦損傷%間接Meta分析
의체랍봉%니막지평%로뇌손상%간접Meta분석
Edaravone%Nimodipine%Head Injury%Indirect Meta-analysis
目的：系统评价依达拉奉和尼莫地平治疗颅脑损伤的疗效。方法：以间接Meta分析的方法对已有研究进行合并，系统评价两种药物治疗颅脑损伤的GOS恢复良好率。结果：依达拉奉和尼莫地平的GOS恢复良好率分别为70.57％和64.24％。结论：在治疗颅脑损伤GOS恢复良好率方面，依达拉奉优于尼莫地平。
目的：繫統評價依達拉奉和尼莫地平治療顱腦損傷的療效。方法：以間接Meta分析的方法對已有研究進行閤併，繫統評價兩種藥物治療顱腦損傷的GOS恢複良好率。結果：依達拉奉和尼莫地平的GOS恢複良好率分彆為70.57％和64.24％。結論：在治療顱腦損傷GOS恢複良好率方麵，依達拉奉優于尼莫地平。
목적：계통평개의체랍봉화니막지평치료로뇌손상적료효。방법：이간접Meta분석적방법대이유연구진행합병，계통평개량충약물치료로뇌손상적GOS회복량호솔。결과：의체랍봉화니막지평적GOS회복량호솔분별위70.57％화64.24％。결론：재치료로뇌손상GOS회복량호솔방면，의체랍봉우우니막지평。
Objective:To systematically evaluate the efficacy of curative effects of treating head injury between edaravone and nimodipine.Methods: The GOS effective rate of excellent or good was taken as effectiveness indicator.An indirect Meta-analy-sis was developed.Results: The GOS rate of excellent or good was 70.57% and 64.24% for edaravone and nimodipine re-spectively.Conclusion: The research showed that GOS rate of excellent or good in edaravone arm is better than that in nimodip-ine arm.
